Page last updated: 2024-08-26

sivelestat and Rhabdomyolysis

sivelestat has been researched along with Rhabdomyolysis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abe, C; Binh, NH; Cuong, NT; Hara, A; Morita, H; Ogura, S	1

Other Studies

1 other study(ies) available for sivelestat and Rhabdomyolysis

Article	Year
Sivelestat improves outcome of crush injury by inhibiting high-mobility group box 1 in rats. Shock (Augusta, Ga.), 2013, Volume: 39, Issue:1 Topics: Acute Lung Injury; Animals; Biomarkers; Carbon Dioxide; Combined Modality Therapy; Crush Syndrome; Drug Evaluation, Preclinical; Fluid Therapy; Glycine; HMGB1 Protein; Liver; Lung; Male; Oxygen; Partial Pressure; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rhabdomyolysis; Serine Proteinase Inhibitors; Sulfonamides; Survival Analysis; Treatment Outcome	2013

Article

Year

Sivelestat improves outcome of crush injury by inhibiting high-mobility group box 1 in rats.

Shock (Augusta, Ga.), 2013, Volume: 39, Issue:1

Topics: Acute Lung Injury; Animals; Biomarkers; Carbon Dioxide; Combined Modality Therapy; Crush Syndrome; Drug Evaluation, Preclinical; Fluid Therapy; Glycine; HMGB1 Protein; Liver; Lung; Male; Oxygen; Partial Pressure; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rhabdomyolysis; Serine Proteinase Inhibitors; Sulfonamides; Survival Analysis; Treatment Outcome

2013